Effect of Interleukin-2 on HIV Treatment Interruption

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00015704
First received: May 1, 2001
Last updated: May 21, 2012
Last verified: May 2012